KLRC1 and neoplasm: However, these NKG2A blockade‐induced beneficial features were not observed in P14 cells originating from the tumor DLN (Figure S5), coinciding with the less observed NKG2A expression of tumor‐specific CD8+ T cells in DLN (Figure 3A).